New Developments in the Pharmacotherapy of Neuropathic Chronic Pelvic Pain

References

• ACOG Practice Bulletin No. 51. Chronic pelvic pain. Obstet. Gynecol. 103(3), 589–605 (2004).
   PubMedGoogle Scholar
• Broder MS, Kanouse DE, Mittman BS, Bernstein SJ. The appropriateness of recommendations for hysterectomy. Obstet. Gynecol. 95(2), 199–205 (2000).
   PubMed Web of Science ®Google Scholar
• Gelbaya TA, El-Halwagy HE. Focus on primary care: chronic pelvic pain in women. Obstet. Gynecol. Surv. 56(12), 757–764 (2001).
   PubMed Web of Science ®Google Scholar
• Mathias SD, Kuppermann M, Liberman RF, Lipschutz RC, Steege JF. Chronic pelvic pain: prevalence, health-related quality of life, and economic correlates. Obstet. Gynecol. 87(3), 321–327 (1996).
   PubMed Web of Science ®Google Scholar
• Howard FM. Surgical treatment of endometriosis. Obstet. Gynecol. Clin. North Am. 38(4), 677–686 (2011).
   PubMed Web of Science ®Google Scholar
• Kraima AC, Van Schaik J, Susan S et al. New insights in the neuroanatomy of the human adult superior hypogastric plexus and hypogastric nerves. Auton. Neurosci. 189, 60–67 (2015).
   PubMed Web of Science ®Google Scholar
• Shoja MM, Sharma A, Mirzayan N et al. Neuroanatomy of the female abdominopelvic region: a review with application to pelvic pain syndromes. Clin. Anat. 26(1), 66–76 (2013).
   PubMed Web of Science ®Google Scholar
• Malykhina AP. Neural mechanisms of pelvic organ cross-sensitization. Neuroscience 149(3), 660–672 (2007).
   PubMed Web of Science ®Google Scholar
• Goucke CR. The management of persistent pain. Med. J. Aust. 178(9), 444–447 (2003).
   PubMed Web of Science ®Google Scholar
• Dworkin RH, Backonja M, Rowbotham MC et al. Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations. Arch. Neurol. 60(11), 1524–1534 (2003).
   PubMed Web of Science ®Google Scholar
• Zieglgansberger W, Berthele A, Tolle TR. Understanding neuropathic pain. CNS Spectrums 10(4), 298–308 (2005).
   PubMed Web of Science ®Google Scholar
• Benzon H, Raja SN, Fishman SE, Liu S, Cohen SP. Essentials of Pain Medicine (3rd Edition). Saunders, Philadelphia, PA, USA, 5–6, 17, 115–146 (2011).
   Google Scholar
• Ro LS, Chang KH. Neuropathic pain: mechanisms and treatments. Chang Gung Med. J. 28(9), 597–605 (2005).
   PubMedGoogle Scholar
• Vercellini P, Trespidi L, De Giorgi O, Cortesi I, Parazzini F, Crosignani PG. Endometriosis and pelvic pain: relation to disease stage and localization. Fertil. Steril. 65(2), 299–304 (1996).
   PubMed Web of Science ®Google Scholar
• Balasch J, Creus M, Fabregues F et al. Visible and non-visible endometriosis at laparoscopy in fertile and infertile women and in patients with chronic pelvic pain: a prospective study. Hum. Reprod. 11(2), 387–391 (1996).
   PubMed Web of Science ®Google Scholar
• Porpora MG, Koninckx PR, Piazze J, Natili M, Colagrande S, Cosmi EV. Correlation between endometriosis and pelvic pain. J. Am. Assoc. Gynecol. Laparosc. 6(4), 429–434 (1999).
   PubMedGoogle Scholar
• As-Sanie S, Harris RE, Harte SE, Tu FF, Neshewat G, Clauw DJ. Increased pressure pain sensitivity in women with chronic pelvic pain. Obstet. Gynecol. 122(5), 1047–1055 (2013).
   PubMed Web of Science ®Google Scholar
• As-Sanie S, Harris RE, Napadow V et al. Changes in regional gray matter volume in women with chronic pelvic pain: a voxel-based morphometry study. Pain 153(5), 1006–1014 (2012).
   PubMed Web of Science ®Google Scholar
• Tu CH, Niddam DM, Chao HT et al. Brain morphological changes associated with cyclic menstrual pain. Pain 150(3), 462–468 (2010).
   PubMed Web of Science ®Google Scholar
• Cheong YC, Smotra G, Williams AC. Non-surgical interventions for the management of chronic pelvic pain. Cochrane Database Syst. Rev. (3), CD008797 (2014).
   PubMed Web of Science ®Google Scholar
• Jabbour HN, Kelly RW, Fraser HM, Critchley HO. Endocrine regulation of menstruation. Endocr. Rev. 27(1), 17–46 (2006).
   PubMed Web of Science ®Google Scholar
• Dawood MY. Primary dysmenorrhea: advances in pathogenesis and management. Obstet. Gynecol. 108(2), 428–441 (2006).
   PubMed Web of Science ®Google Scholar
• Garcia Rodriguez LA. Nonsteroidal antiinflammatory drugs, ulcers and risk: a collaborative meta-analysis. Semin. Arthritis Rheum. 26(6 Suppl. 1), 16–20 (1997).
   PubMed Web of Science ®Google Scholar
• Latthe PM, Champaneria R, Khan KS. Dysmenorrhoea. BMJ Clin. Evid. 2011, pii:0813 (2011).
   PubMedGoogle Scholar
• Marjoribanks J, Ayeleke RO, Farquhar C, Proctor M. Nonsteroidal anti-inflammatory drugs for dysmenorrhoea. Cochrane Database Syst. Rev. (7), CD001751 (2015).
   PubMed Web of Science ®Google Scholar
• Vane JR, Botting RM. The mechanism of action of aspirin. Thromb. Res. 110(5–6), 255–258 (2003).
   PubMed Web of Science ®Google Scholar
• Makin AJ, Williams R. Acetaminophen-induced hepatotoxicity: predisposing factors and treatments. Adv. Intern. Med. 42, 453–483 (1997).
   PubMedGoogle Scholar
• Ali Z, Burnett I, Eccles R et al. Efficacy of a paracetamol and caffeine combination in the treatment of the key symptoms of primary dysmenorrhoea. Curr. Med. Res. Opin. 23(4), 841–851 (2007).
   PubMed Web of Science ®Google Scholar
• Eccles R, Holbrook A, Jawad M. A double-blind, randomised, crossover study of two doses of a single-tablet combination of ibuprofen/paracetamol and placebo for primary dysmenorrhoea. Curr. Med. Res. Opin. 26(11), 2689–2699 (2010).
   PubMed Web of Science ®Google Scholar
• Baranowski AP, Lee J, Price C, Hughes J. Pelvic pain: a pathway for care developed for both men and women by the British Pain Society. Br. J. Anaesth. 112(3), 452–459 (2014).
   PubMed Web of Science ®Google Scholar
• Healy JR, Bezawada P, Shim J et al. Synthesis, modeling, and pharmacological evaluation of UMB 425, a mixed mu agonist/delta antagonist opioid analgesic with reduced tolerance liabilities. ACS Chem. Neurosci. 4(9), 1256–1266 (2013).
   PubMed Web of Science ®Google Scholar
• Kremer M, Salvat E, Muller A, Yalcin I, Barrot M. Antidepressants and gabapentinoids in neuropathic pain: Mechanistic insights. Neuroscience doi:10.1016/j.neuroscience.2016.06.057 (2016) ( Epub ahead of print).
   PubMed Web of Science ®Google Scholar
• Sator-Katzenschlager SM, Scharbert G, Kress HG et al. Chronic pelvic pain treated with gabapentin and amitriptyline: a randomized controlled pilot study. Wiener klinische Wochenschrift 117(21–22), 761–768 (2005).
   PubMed Web of Science ®Google Scholar
• An update on the drug treatment of neuropathic pain. Part 1: antidepressants. Drug Ther. Bull. 50(10), 114–117 (2012).
   PubMedGoogle Scholar
• Beresin EV. Imipramine in the treatment of chronic pelvic pain. Psychosomatics 27(4), 294–296 (1986).
   PubMed Web of Science ®Google Scholar
• Walker EA, Roy-Byrne PP, Katon WJ, Jemelka R. An open trial of nortriptyline in women with chronic pelvic pain. Int. J. Psychiatry Med. 21(3), 245–252 (1991).
   PubMed Web of Science ®Google Scholar
• Foster HE, Jr, Hanno PM, Nickel JC et al. Effect of amitriptyline on symptoms in treatment naive patients with interstitial cystitis/painful bladder syndrome. J. Urol. 183(5), 1853–1858 (2010).
   PubMed Web of Science ®Google Scholar
• Hillelsohn JH, Rais-Bahrami S, Bagadiya N, Kashan M, Weiss GH. Use of desipramine for the treatment of overactive bladder refractory to antimuscarinic therapy. Urol. J. 10(4), 1114–1118 (2013).
   Web of Science ®Google Scholar
• Pranikoff K, Constantino G. The use of amitriptyline in patients with urinary frequency and pain. Urology 51(Suppl. 5A), 179–181 (1998).
   PubMed Web of Science ®Google Scholar
• Van Ophoven A, Pokupic S, Heinecke A, Hertle L. A prospective, randomized, placebo controlled, double-blind study of amitriptyline for the treatment of interstitial cystitis. J. Urol. 172(2), 533–536 (2004).
   PubMed Web of Science ®Google Scholar
• Engel CC, Jr, Walker EA, Engel AL, Bullis J, Armstrong A. A randomized, double-blind crossover trial of sertraline in women with chronic pelvic pain. J. Psychosom. Res. 44(2), 203–207 (1998).
   PubMed Web of Science ®Google Scholar
• Papandreou C, Skapinakis P, Giannakis D, Sofikitis N, Mavreas V. Antidepressant drugs for chronic urological pelvic pain: an evidence-based review. Adv. Urol. 2009, 797031 (2009).
   PubMedGoogle Scholar
• Van Ophoven A, Hertle L. The dual serotonin and noradrenaline reuptake inhibitor duloxetine for the treatment of interstitial cystitis: results of an observational study. J. Urol. 177(2), 552–555 (2007).
   PubMed Web of Science ®Google Scholar
• Lunn MP, Hughes RA, Wiffen PJ. Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia. Cochrane Database Syst. Rev. (1), CD007115 (2014).
   PubMed Web of Science ®Google Scholar
• Lewis SC, Bhattacharya S, Wu O et al. Gabapentin for the management of chronic pelvic pain in women (GaPP1): a pilot randomised controlled trial. PLoS ONE 11(4), e0153037 (2016).
   PubMed Web of Science ®Google Scholar
• Pontari MA, Krieger JN, Litwin MS et al. Pregabalin for the treatment of men with chronic prostatitis/chronic pelvic pain syndrome: a randomized controlled trial. Arch. Intern. Med. 170(17), 1586–1593 (2010).
   PubMed Web of Science ®Google Scholar
• Crofford LJ, Rowbotham MC, Mease PJ et al. Pregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trial. Arthritis Rheum. 52(4), 1264–1273 (2005).
   PubMed Web of Science ®Google Scholar
• Dworkin RH, Corbin AE, Young JP Jr et al. Pregabalin for the treatment of postherpetic neuralgia: a randomized, placebo-controlled trial. Neurology 60(8), 1274–1283 (2003).
   PubMed Web of Science ®Google Scholar
• Rosenstock J, Tuchman M, Lamoreaux L, Sharma U. Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial. Pain 110(3), 628–638 (2004).
   PubMed Web of Science ®Google Scholar
• Bhattacharya A, Wickenden AD, Chaplan SR. Sodium channel blockers for the treatment of neuropathic pain. Neurotherapeutics 6(4), 663–678 (2009).
   PubMed Web of Science ®Google Scholar
• Farquhar CM, Rogers V, Franks S, Pearce S, Wadsworth J, Beard RW. A randomized controlled trial of medroxyprogesterone acetate and psychotherapy for the treatment of pelvic congestion. Br. J. Obstet. Gynaecol. 96(10), 1153–1162 (1989).
   PubMedGoogle Scholar
• Poli-Neto OB, Filho AA, Rosa e Silva JC, Barbosa Hde F, Candido Dos Reis FJ, Nogueira AA. Increased capsaicin receptor TRPV1 in the peritoneum of women with chronic pelvic pain. Clin. J. Pain 25(3), 218–222 (2009).
   PubMed Web of Science ®Google Scholar
• Rocha MG, E Silva JC, Ribeiro Da Silva A, Candido Dos Reis FJ, Nogueira AA, Poli-Neto OB. TRPV1 expression on peritoneal endometriosis foci is associated with chronic pelvic pain. Reprod. Sci. 18(6), 511–515 (2011).
   PubMed Web of Science ®Google Scholar
• Turini D, Beneforti P, Spinelli M, Malagutti S, Lazzeri M. Heat/burning sensation induced by topical application of capsaicin on perineal cutaneous area: new approach in diagnosis and treatment of chronic prostatitis/chronic pelvic pain syndrome? Urology 67(5), 910–913 (2006).
   PubMed Web of Science ®Google Scholar
• Theile JW, Cummins TR. Recent developments regarding voltage-gated sodium channel blockers for the treatment of inherited and acquired neuropathic pain syndromes. Front. Pharmacol. 2, 54 (2011).
   PubMed Web of Science ®Google Scholar
• Dressler D, Adib Saberi F. Botulinum toxin: mechanisms of action. Eur. Neurol. 53(1), 3–9 (2005).
   PubMed Web of Science ®Google Scholar
• Arezzo JC. Possible mechanisms for the effects of botulinum toxin on pain. Clin. J. Pain 18(Suppl. 6), S125–S132 (2002).
   PubMed Web of Science ®Google Scholar
• Jarvis SK, Abbott JA, Lenart MB, Steensma A, Vancaillie TG. Pilot study of botulinum toxin type A in the treatment of chronic pelvic pain associated with spasm of the levator ani muscles. Aust. NZ J. Obstet. Gynaecol. 44(1), 46–50 (2004).
   PubMed Web of Science ®Google Scholar
• Abbott JA, Jarvis SK, Lyons SD, Thomson A, Vancaille TG. Botulinum toxin type A for chronic pain and pelvic floor spasm in women: a randomized controlled trial. Obstet. Gynecol. 108(4), 915–923 (2006).
   PubMed Web of Science ®Google Scholar
• Kim DW, Lee SK, Ahnn J. Botulinum Toxin as a Pain Killer: Players and Actions in Antinociception. Toxins (Basel) 7(7), 2435–2453 (2015).
   PubMed Web of Science ®Google Scholar
• Santos J, Alarcao J, Fareleira F, Vaz-Carneiro A, Costa J. Tapentadol for chronic musculoskeletal pain in adults. Cochrane Database Syst. Rev. (5), CD009923 (2015).
   Web of Science ®Google Scholar
• Walczak JS, Price TJ, Cervero F. Cannabinoid CB1 receptors are expressed in the mouse urinary bladder and their activation modulates afferent bladder activity. Neuroscience 159(3), 1154–1163 (2009).
   PubMed Web of Science ®Google Scholar
• Mukerji G, Yiangou Y, Agarwal SK, Anand P. Increased cannabinoid receptor 1-immunoreactive nerve fibers in overactive and painful bladder disorders and their correlation with symptoms. Urology 75(6), 1514.e15–e20 (2010).
   PubMed Web of Science ®Google Scholar
• Moulin D, Boulanger A, Clark AJ et al. Pharmacological management of chronic neuropathic pain: revised consensus statement from the Canadian Pain Society. Pain Res. Manag. 19(6), 328–335 (2014).
   PubMed Web of Science ®Google Scholar
• Dutta A, Mckie S, Deakin JF. Ketamine and other potential glutamate antidepressants. Psychiatry Res. 225(1–2), 1–13 (2015).
   PubMed Web of Science ®Google Scholar
• Mcroberts JA, Coutinho SV, Marvizon JC et al. Role of peripheral N-methyl-D-aspartate (NMDA) receptors in visceral nociception in rats. Gastroenterology 120(7), 1737–1748 (2001).
   PubMed Web of Science ®Google Scholar
• Hermanussen M, Tresguerres JA. A new anti-obesity drug treatment: first clinical evidence that, antagonising glutamate-gated Ca2+ ion channels with memantine normalises binge-eating disorders. Econ. Hum. Biol. 3(2), 329–337 (2005).
   PubMed Web of Science ®Google Scholar
• Serra G, Demontis F, Serra F et al. Memantine: New prospective in bipolar disorder treatment. World J. Psychiatry 4(4), 80–90 (2014).
   PubMedGoogle Scholar
• Krystal JH. N-methyl-D-aspartate glutamate receptor antagonists and the promise of rapid-acting antidepressants. Arch. Gen. Psychiatry 67(11), 1110–1111 (2010).
   PubMed Web of Science ®Google Scholar
• John JP, Lukose A, Manjunath S. Off-label use of memantine as adjunctive treatment in schizophrenia: a retrospective case series study. Pharmacopsychiatry 47(6), 202–209 (2014).
   PubMed Web of Science ®Google Scholar
• Morel V, Etienne M, Wattiez AS et al. Memantine, a promising drug for the prevention of neuropathic pain in rat. Eur. J. Pharmacol. 721(1–3), 382–390 (2013).
   PubMed Web of Science ®Google Scholar
• Nickel JC, Atkinson G, Krieger JN et al. Preliminary assessment of safety and efficacy in proof-of-concept, randomized clinical trial of tanezumab for chronic prostatitis/chronic pelvic pain syndrome. Urology 80(5), 1105–1110 (2012).
   PubMed Web of Science ®Google Scholar
• Barcena De Arellano ML, Arnold J, Vercellino F, Chiantera V, Schneider A, Mechsner S. Overexpression of nerve growth factor in peritoneal fluid from women with endometriosis may promote neurite outgrowth in endometriotic lesions. Fertil. Steril. 95(3), 1123–1126 (2011).
   PubMed Web of Science ®Google Scholar
• Kajitani T, Maruyama T, Asada H et al. Possible involvement of nerve growth factor in dysmenorrhea and dyspareunia associated with endometriosis. Endocr. J. 60(10), 1155–1164 (2013).
   PubMed Web of Science ®Google Scholar
• Jarrell JF, Vilos GA, Allaire C et al. Consensus guidelines for the management of chronic pelvic pain. J. Obstet. Gynaecol. Can. 27(8), 781–826 (2005).
   PubMedGoogle Scholar
• Jackson T, Thomas S, Stabile V, Shotwell M, Han X, Mcqueen K. A systematic review and meta-analysis of the global burden of chronic pain without clear etiology in low- and middle-income countries: trends in heterogeneous data and a proposal for new assessment methods. Anesth. Analg. 123(3), 739–748 (2016).
   PubMed Web of Science ®Google Scholar